Award Timing Disclosure |
12 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2025
USD ($)
$ / shares
| |||||||||||||||||||||||||
| Award Timing Disclosures [Line Items] | |||||||||||||||||||||||||
| Award Timing MNPI Disclosure |
Policies and Practices Related to the Grant of Certain Equity Awards
The Compensation Committee approves equity awards granted to the named executive officers on or before the grant date. The Compensation Committee does take material nonpublic information into account when determining the timing and terms of such awards. We have timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.
As shown in the table below, in 2025, we awarded stock options to the named executive officers during certain periods beginning four business days before the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K disclosing material non-public information and ending one business day after the filing or furnishing of such report with the SEC.
(1) For completeness, all required Form 8-K filings during the covered periods have been assumed to include material non-public information. (2) On 4/21/2025, the Company filed a Form 8-K disclosing that James W. Kupiec, M.D., the Company's former Chief Medical Officer, had informed the Company of his intent to retire and tendered his resignation as the Company’s Chief Medical Officer, effective as of May 9, 2025. In addition, the Form 8-K disclosed Amended and Restated Employment Agreements for Mr. Cook and Mr. Schoen. The Amended and Restated Employment Agreement for Mr. Cook disclosed his revised annual base salary. The Amended and Restated Employment Agreements for Messrs. Cook and Schoen disclosed annual bonus targets at 40% of base salary as well as potential benefits for termination without cause. See the discussion in the section entitled “Executive Compensation and Other Matters – Employment and Severance Arrangements” of this Proxy Statement. |
||||||||||||||||||||||||
| Award Timing Method | The Compensation Committee approves equity awards granted to the named executive officers on or before the grant date. The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of such awards. We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. | ||||||||||||||||||||||||
| Award Timing Predetermined | false | ||||||||||||||||||||||||
| Award Timing MNPI Considered | false | ||||||||||||||||||||||||
| MNPI Disclosure Timed for Compensation Value | false | ||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures, Table |
|
||||||||||||||||||||||||
| Richard J. Barry [Member] | |||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | |||||||||||||||||||||||||
| Name | Richard J. Barry | ||||||||||||||||||||||||
| Underlying Securities | 350,000 | ||||||||||||||||||||||||
| Exercise Price | $ / shares | $ 1.44 | ||||||||||||||||||||||||
| Fair Value as of Grant Date | $ | $ 490,035 | ||||||||||||||||||||||||
| Underlying Security Market Price Change | 10.4 | ||||||||||||||||||||||||
| R. Christopher Cook [Member] | |||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | |||||||||||||||||||||||||
| Name | R. Christopher Cook | ||||||||||||||||||||||||
| Underlying Securities | 100,000 | ||||||||||||||||||||||||
| Exercise Price | $ / shares | $ 1.44 | ||||||||||||||||||||||||
| Fair Value as of Grant Date | $ | $ 140,010 | ||||||||||||||||||||||||
| Underlying Security Market Price Change | 10.4 | ||||||||||||||||||||||||
| Eric J. Schoen [Member] | |||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | |||||||||||||||||||||||||
| Name | Eric J. Schoen | ||||||||||||||||||||||||
| Underlying Securities | 100,000 | ||||||||||||||||||||||||
| Exercise Price | $ / shares | $ 1.44 | ||||||||||||||||||||||||
| Fair Value as of Grant Date | $ | $ 140,010 | ||||||||||||||||||||||||
| Underlying Security Market Price Change | 10.4 |